Tenor Capital Management’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-166,666
| Closed | -$242K | – | 348 |
|
|
2024
Q1 | $242K | Hold |
166,666
| – | – | ﹤0.01% | 179 |
|
|
2023
Q4 | $16.7K | Hold |
166,666
| – | – | ﹤0.01% | 216 |
|
|
2023
Q3 | $25K | Hold |
166,666
| – | – | ﹤0.01% | 218 |
|
|
2023
Q2 | $15K | Hold |
166,666
| – | – | ﹤0.01% | 259 |
|
|
2023
Q1 | $9.17K | Hold |
166,666
| – | – | ﹤0.01% | 354 |
|
|
2022
Q4 | $7.6K | Hold |
166,666
| – | – | ﹤0.01% | 445 |
|
|
2022
Q3 | $11K | Hold |
166,666
| – | – | ﹤0.01% | 575 |
|
|
2022
Q2 | $25K | Hold |
166,666
| – | – | ﹤0.01% | 564 |
|
|
2022
Q1 | $50K | Hold |
166,666
| – | – | ﹤0.01% | 592 |
|
|
2021
Q4 | $85K | Hold |
166,666
| – | – | ﹤0.01% | 571 |
|
|
2021
Q3 | $98K | Hold |
166,666
| – | – | ﹤0.01% | 511 |
|
|
2021
Q2 | $167K | Buy |
+166,666
| New | +$167K | ﹤0.01% | 507 |
|